Twist Bioscience
TWST
221 hedge funds and large institutions have $2.04B invested in Twist Bioscience in 2022 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 74 increasing their positions, 61 reducing their positions, and 19 closing their positions.
105% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 19
48% more call options, than puts
Call options by funds: $5.54M | Put options by funds: $3.73M
21% more repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 61
8% more funds holding
Funds holding: 204 → 221 (+17)
2% more capital invested
Capital invested by funds: $2.01B → $2.04B (+$36M)
0.34% more ownership
Funds ownership: 103.14% → 103.48% (+0.34%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VOYA Investment Management
Atlanta,
Georgia
|
+$65.3M |
| 2 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$37.8M |
| 3 |
BWLSA
Blue Water Life Science Advisors
Larkspur,
California
|
+$34.2M |
| 4 |
Fisher Asset Management
Camas,
Washington
|
+$24.3M |
| 5 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$17.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Allianz Asset Management
Munich,
Germany
|
-$54.5M |
| 2 |
JSP
Jackson Square Partners
Larkspur,
California
|
-$45.7M |
| 3 |
State Street
Boston,
Massachusetts
|
-$40.5M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$36.7M |
| 5 |
William Blair Investment Management
Chicago,
Illinois
|
-$31.6M |
TWST Hedge Fund Activity: Q3 2022 in Review
221 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Twist Bioscience (TWST) for Q3 2022, worth a combined $2.04B — up 1.8% from $2.01B a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new TWST positions and 19 closed out — a net gain of 20 holders — while 74 added to existing stakes and 61 trimmed.
The largest buyer was VOYA Investment Management, adding an estimated $65.3M. The largest seller was Allianz Asset Management, exiting entirely with an estimated $54.5M sold.
- 221 institutional investors held Twist Bioscience (TWST) as of Q3 2022, up from 204 in Q2 2022.
- Funds reported $2.04B of Twist Bioscience stock for Q3 2022, up 1.8% quarter-over-quarter.
- 39 funds opened new Twist Bioscience positions in Q3 2022 and 19 closed out, a net change of +20 holders.
- The largest Twist Bioscience buyer in Q3 2022 was VOYA Investment Management, an estimated $65.3M added.
- The largest Twist Bioscience seller in Q3 2022 was Allianz Asset Management, an estimated $54.5M sold.
Based on aggregated 13F filings for Q3 2022.